BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1251 related articles for article (PubMed ID: 19390308)

  • 21. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
    Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
    J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Histopathology of malignant lymphomas].
    Yamabe H
    Rinsho Byori; 1990 Apr; 38(4):386-9. PubMed ID: 2195192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presentation, staging and diagnosis of lymphoma: a clinical perspective.
    Hingorjo MR; Syed S
    J Ayub Med Coll Abbottabad; 2008; 20(4):100-3. PubMed ID: 19999217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hodgkin's lymphomas: classification, diagnosis, and grading.
    Harris NL
    Semin Hematol; 1999 Jul; 36(3):220-32. PubMed ID: 10462322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunophenotyping of Hodgkin's disease--an aid to its classification.
    Kalyan K; Basu D; Soundararaghavan J
    Indian J Pathol Microbiol; 2006 Apr; 49(2):173-7. PubMed ID: 16933709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathology of Hodgkin's lymphoma].
    Hansmann ML; Willenbrock K
    Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and expression of CT45 in Hodgkin's lymphoma.
    Heidebrecht HJ; Claviez A; Kruse ML; Pollmann M; Buck F; Harder S; Tiemann M; Dörffel W; Parwaresch R
    Clin Cancer Res; 2006 Aug; 12(16):4804-11. PubMed ID: 16914565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease.
    Regula DP; Hoppe RT; Weiss LM
    N Engl J Med; 1988 Jan; 318(4):214-9. PubMed ID: 3336412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological correlations of TIMP-1 and TIMP-2 in Hodgkin's lymphoma.
    Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
    Eur J Haematol; 2004 Jan; 72(1):1-9. PubMed ID: 14962256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphomas in Iran.
    Hashemi-Bahremani M; Parwaresch MR; Tabrizchi H; Gupta RK; Raffii MR
    Arch Iran Med; 2007 Jul; 10(3):343-8. PubMed ID: 17604472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classical Hodgkin's lymphoma presenting as a testicular mass: report of a case.
    Seliem RM; Chikwava K; Swerdlow SH; Young RH; Ferry JA
    Int J Surg Pathol; 2007 Apr; 15(2):207-12. PubMed ID: 17478785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease: two closely related entities?
    Schmidt U; Metz KA; Leder LD
    Br J Haematol; 1995 Jun; 90(2):398-403. PubMed ID: 7794762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bioptic typing and classification of Hodgkin's lymphomas--status in 1998].
    Plank L; Fakan F
    Vnitr Lek; 1999 Mar; 45(3):186-92. PubMed ID: 15641245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hodgkin's disease--a histologic problem].
    Lauritzen AF; Specht L; Nissen NI; Hou-Jensen K
    Ugeskr Laeger; 1989 Nov; 151(47):3138-40. PubMed ID: 2688235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinico-Hematological Findings for Classical Hodgkin's Lymphoma: an Institutional Experience.
    Sultan S; Irfan SM; Parveen S; Ali S
    Asian Pac J Cancer Prev; 2016; 17(8):4009-11. PubMed ID: 27644653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinico-pathological study of Hodgkin's lymphoma in a cancer center in Taiwan.
    Lee MY; Tan TD; Feng AC
    Clin Lab Haematol; 2005 Dec; 27(6):379-83. PubMed ID: 16307539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell rich b-cell non-hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance hodgkin's disease.
    De Jong D; Van Gorp J; Sie-Go D; Van Heerde P
    Histopathology; 1996 Jan; 28(1):15-24. PubMed ID: 8838116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease.
    Kant JA; Hubbard SM; Longo DL; Simon RM; DeVita VT; Jaffe ES
    J Clin Oncol; 1986 Mar; 4(3):284-94. PubMed ID: 3754003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution.
    Lee MY; Tan TD; Feng AC; Liu MC
    Am J Hematol; 2006 Aug; 81(8):568-75. PubMed ID: 16823825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nodular lymphocyte predominant Hodgkin lymphoma.
    Lee AI; LaCasce AS
    Oncologist; 2009 Jul; 14(7):739-51. PubMed ID: 19605845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.